SDC1 and Miyoshi myopathy: The disappearance of histone impact after CD138 knock-down, and after heparin treatment, a competitor of HSPG for their binding to cationic ligands [11], and the co-localization of histones with CD138 confirmed that histone activity requires binding to CD138 on MM cells.